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Inappropriate antimicrobial use has been shown to be an important determinant of the emer-
gence of antimicrobial resistance (AMR). Health information technology (HIT) in the form of
Computerised Decision Support (CDS) represents an option for improving antimicrobial pre-
scribing and containing AMR.
Objectives
To evaluate the evidence for CDS in improving quantitative and qualitative measures of anti-
biotic prescribing in inpatient hospital settings.
Methods
A systematic literature search was conducted of articles published from inception to 20th
December 2014 using eight electronic databases: MEDLINE, EMBASE, PUBMED, Web of
Science, CINAHL, Cochrane Library, HMIC and PsychINFo. An updated systematic litera-
ture search was conducted from January 1st 2015 to October 1st 2016 using PUBMED. The
search strategy used combinations of the following terms: (electronic prescribing) OR (clini-
cal decision support) AND (antibiotic or antibacterial or antimicrobial) AND (hospital or sec-
ondary care or inpatient). Studies were evaluated for quality using a 10-point rating scale.
Results
Eighty-one studies were identified matching the inclusion criteria. Seven outcome measures
were evaluated: adequacy of antibiotic coverage, mortality, volume of antibiotic usage,
length of stay, antibiotic cost, compliance with guidelines, antimicrobial resistance, and CDS
implementation and uptake. Meta-analysis of pooled outcomes showed CDS significantly
improved the adequacy of antibiotic coverage (n = 13; odds ratio [OR], 2.11 [95% CI, 1.67 to
2.66, p 0.00001]). Also, CDS was associated with marginally lowered mortality (n = 20;
OR, 0.85 [CI, 0.75 to 0.96, p = 0.01]). CDS was associated with lower antibiotic utilisation,
increased compliance with antibiotic guidelines and reductions in antimicrobial resistance.
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Conflicting effects of CDS on length of stay, antibiotic costs and system uptake were also
noted.
Conclusions
CDS has the potential to improve the adequacy of antibiotic coverage and marginally
decrease mortality in hospital-related settings.
Introduction
Antimicrobials have saved millions of lives since their introduction[1] however; antimicrobial
resistance (AMR) has increased over the past four decades.[2] Evidence shows that 30%-50%
of antimicrobial prescribing is sub-optimal.[3] Inappropriate antimicrobial use has been
shown to be an important determinant of the emergence and persistence of AMR.[2] This pat-
tern of irrational use in hospitals and the relative reduction in development of new antibiotic
entities pose a challenge for clinicians, as their options to treat infections, especially those
caused by resistant pathogens, become limited.
The use of health information technology (HIT) is one strategy to optimise antibiotic use in
health care settings. Over the last twenty years, there have been rapid advances and investment
in HIT, manifesting as an increased uptake of the use of computers in healthcare. The NHS
embraces the role of HIT in optimising the quality of care and patient safety. In the UK, £12.8
billion has been invested in the National Programme for Information Technology (NPfIT) by
the National Health Service (NHS).[4] Computerised Decision Support (CDS) represents a
potential solution for improving antimicrobial prescribing and containing antimicrobial resis-
tance by supporting clinical decision making[5,6] thus optimising antibiotic use and improv-
ing patient outcomes. It potentially plays an important role in guiding prescribing practices
such as antibiotic selection and dosing suggestions, alerting potential adverse drug reactions
and drug allergies.
Two previous systematic reviews focused on the impact CDS on antibiotic use in primary
care[7] and included non-computerised decision support.[8] Another more recent systematic
review addressed a similar research question and examined the impact of HIT interventions
on antimicrobial prescribing.[9] The scope, design and timing of these reviews may have
excluded relevant CDS studies that match the inclusion criteria in this review. The aim of the
present study was to evaluate the current state of evidence for CDS interventions on antibiotic
use in the hospital inpatient setting. Meta-analysis was conducted using odds ratio to assess
the impact of CDS on the adequacy of antibiotic coverage and mortality and to assess the
impact of CDS, using relative differences, on length of stay, volume of antibiotic use, antimi-
crobial resistance and compliance with guidelines.
Methods
Data source and study selection
A systematic literature search was conducted utilising eight online databases including MED-
LINE, EMBASE, PUBMED, Web of Science, CINAHL, Cochrane Library, HMIC, and Psy-
cINFO. The search was conducted from inception to 20th December, 2014. An updated
literature search was conducted from January 1st 2015 to October 1st 2016 using PUBMED.
The searches were conducted using a strategy based upon combinations of the following
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terms: (electronic prescribing) OR (clinical decision support) AND (antibiotic or antibacterial
or antimicrobial) AND (hospital or secondary care or inpatient). The search strategy appears
in S1 Appendix, PRISMA search strategy details. This was supported by use of a checklist
S1 Checklist PRISMA 2009 checklist to ensure that PRISMA principles were followed during
the process.
Titles and abstracts from retrieved references were examined by two reviewers (FA and
CEC) to determine the potential inclusion eligibility. Full texts of potential studies were exam-
ined for eligibility against the review inclusion criteria. Bibliographies of retrieved articles and
previous systematic reviews were examined to identify additional articles that could have been
missed by this search strategy.
Inclusion and exclusion criteria
Criteria for inclusion in the systematic review were: (i) conducted by health care providers in
inpatient or ICU or emergency (ED) settings (ii) the intervention involved CDS aimed at
improving antibiotic prescribing at the point of care and (iii) the intervention was compared to
no intervention, non-CDS intervention (non-electronic decision support) or to an intervention
with CDS of different features. For the purpose of the systematic review, CDS was defined as a
computer-based system designed to help directly in clinical decision making in which charac-
teristics of individual patients are utilised to generate recommendations presented to clinicians
at the point of care in a passive or active format such as alerts, reminders and guidelines.[10–12]
Non-electronic CDS studies, non-hospital based studies, qualitative studies, case reports,
case series studies, conference abstracts, commentaries, and letters, papers examining the per-
formance of the system as opposed to its impact on antibiotic prescribing were excluded. In
the case where a study had an unclear inclusion status, conflicts were resolved and consensus
was reached by a third reviewer (JFM).
Data extraction and quality assessment
A custom data extraction form was created to match the specific needs of the review. Data
related to study design, participants, interventions, comparators, outcomes, and main findings
were extracted by one reviewer (FA) and confirmed by another (CEC). Disagreements were
resolved by consensus, with a third investigator (JFM). When studies did not report sufficient
data to allow pooling for meta-analysis, results were summarised qualitatively using relative
differences. Email requests for additional data were made to authors of papers containing
insufficient information to be included in the meta-analyses.
The quality of included studies was assessed using a 10-point rating scale previously used to
evaluate CDS studies (see Table 1).[9,13–15] The scale included five domains (2 points per
domain): method of allocation of study groups, unit of allocation, presence of baseline differ-
ences between groups, objectivity of outcome measures, and completeness of follow-up for
appropriate unit of analysis. Assessment of the methodological quality of the eligible studies
was undertaken independently by two reviewers (FA, CEC). Reviewer disagreements were
resolved by a third reviewer (JFM).
Data analysis and statistical analysis
A defined set of outcomes essential in estimating the effect of CDS in optimising antibiotic use
shaped the synthesis process. Meta-analysis was conducted when studies evaluated the same
outcome and had sufficient data to allow pooling. All studies were eligible for consideration
for inclusion in the meta-analysis as all assessed the impact of CDS on antibiotic prescribing in
the hospital inpatient setting. The meta-analysis focused on two outcomes: adequacy of
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antibiotic coverage (13 studies) and mortality (20 studies). Odds ratios and 95% confidence
intervals (CIs) were calculated for each trial by reconstructing tables based on the number of
patients randomly allocated and the number of patients with the outcome of interest. Inter-
study variance was assessed using the Tau2 test. Inter-study heterogeneity was assessed using
the Chi2 test and the I2 statistics. An I2 value higher than 75% was regarded as ‘significant het-
erogeneity’ and a value less than 40% was considered ‘not significant heterogeneity’. Study
results were considered statistically significant if the p value was below 0.05. Summary esti-
mates were calculated by using the Mantel Haenszel random–effects model[16] in Reviewer
Manager ((RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane
Collaboration, 2014). This enabled an estimate of variation between studies to be made by
comparing study results with a fixed effect meta-analysis result.
The calculated heterogeneity of included studies and outcome assessment precluded pool-
ing of data for some outcomes, in which case percentage mean difference analyses of such out-
comes were conducted. To facilitate comparison across studies, units of volume of antibiotic
use were converted to defined daily doses per 1000 patient-days (DDD/1000 patient-days),
while units for drug costs were left in the currency of the country of origin. Compliance with
antibiotic guidelines was measured by percentage mean differences between intervention and




For this systematic review, the PRISMA statement was adopted[17] as detailed in Figure A in
S1 File, PRISMA checklist highlighting study selection, which shows the results of the search
and selection process. After screening 2459 studies, the removal of 237 duplicates between
databases, the addition of 18 studies from bibliographies of included studies and previous sys-
tematic reviews, and the addition of 10 studies from the second updated PUBMED search, a
total 378 full-text studies were reviewed. Of these, 297 studies did not meet inclusion criteria
for the following reasons: were not conducted in secondary or tertiary care settings, did not
answer research questions, or had inadequate study design. The characteristics and a bibliogra-
phy of the 81 included studies are summarized in S1 Table, Characteristics of included studies
(Table A). References for included studies (List A). Twenty-six studies assessed mortality, 25
assessed length of stay, 19 assessed volume of antibiotic usage, 16 assessed adequacy of
Table 1. Detail of the 10-point Quality Assessment Scale used in the present study.
1. Method of allocation of study groups
2 = Random, 1 = Quasi-random, ) = Selected concurrent controls
2. Unit of allocation
2 = Cluster (e.g. practice), 1 = Physician, 0 = Patients
3. Presence of baseline differences between groups
2 = No baseline differences present or appropriate statistical adjustments made
1 = Baseline differences present and no statistical adjustment made
0 = Baseline characteristics not reported
4. Objectivity of outcome measures
2 = Objective outcomes or subjective outcomes with blinded assessment
1 = Subjective outcomes with no blinding but clearly defined assessment criteria
0 = Subjective outcomes with no blinding and poorly defined assessment
5. Completeness of follow up for appropriate unit of analysis
2 = >90%, 1 = 80–90%, 0 = <80%
https://doi.org/10.1371/journal.pone.0183062.t001
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antibiotic coverage, 15 assessed CDS uptake and use, 15 assessed cost of antibiotics, 10 assessed
compliance with guidelines, and 4 assessed antimicrobial resistance. The majority of studies
were conducted in the United States (45 studies).
CDS interventions
The classification of CDS interventions by Baysari and co-workers was adopted in the present
review.[9] CDS interventions found in this systematic review took four main forms: (1) stand-
alone computerised decision support systems (CDSSs), (2) decision support embedded within
a hospital’s electronic medical record (EMR) or computerized provider order entry (CPOE)
system, (3) computerized antimicrobial approval systems, and (4) antibiotic surveillance sys-
tems. Interventions were evaluated against usual care, no CDS, paper-based decision support
or CDS.
Quality of studies
This systematic review indicates that the current state of evidence for CDS in optimising anti-
biotic use is poor and is limited to non-Cochrane study designs as there were few randomised
studies found in the literature. The majority of studies identified used before-and-after designs
with very few including a control group. The included studies achieved an average score of 5.7
of a possible total of 10 on the rating scale. Random allocation of health care professionals,
patients or units to a CDS intervention was rare. The majority of studies assessed an objective
outcome measure (length of stay) or used a subjective measure with blinded assessment.
Outcomes of CDS use
Adequacy of antibiotic coverage. Sixteen studies reported on the adequacy of antibiotic
coverage. [1,5,18–31] Adequacy of antibiotic coverage was defined in individual studies and
included retrospective review of antibiotic recommendations made by CDS systems and mea-
sures of prescriber compliance with published guidelines when CDS was in use. Thirteen of
these contained sufficient information to be included in the meta-analysis [1,5,18,21,23–31],
ten of which (1, 22, 24–27, 29–32) reported a statistically significant effect of CDS on the ade-
quacy of antibiotic coverage. Three studies were not included in the meta-analysis since they
presented insufficient data to allow pooling of outcomes. Individual and pooled estimates are
shown in Figure B in S1 File, Forest plot from individual studies and meta-analysis for ade-
quacy of antibiotic coverage.). Overall, CDS interventions were associated with an increase in
adequacy of antibiotic coverage based on the random effects model [OR = 2.11, 95% CI, 1.67
to 2.66, p< 0.00001]. There was evidence of heterogeneity between studies (Chi2 = 55.85,
df = 15, I2 = 73%, p< 0.00001) (Figure B in S1 File Forest plot from individual studies and
meta-analysis for adequacy of antibiotic coverage. There was evidence of an effect of CDS
interventions on the adequacy of antibiotic coverage for Cochrane compliant studies
[OR = 1.47, 95% CI, 1.03 to 2.10, p = 0.03], and for non-Cochrane studies [OR = 2.18, 95% CI,
1.69 to 2.80, p< 0.00001] (Figure B in S1 File Forest plot from individual studies and meta-
analysis for adequacy of antibiotic coverage).
Mortality. Twenty-six studies evaluated the impact of CDS on mortality
[1,18,22,24,25,30,32–50]. Twenty studies contained sufficient information to be included in
the meta-analysis [1,18,24,25,30,32–36,40–45,47–50], four of which reported a statistically sig-
nificant effect of CDS on mortality. Six studies were not included in the meta-analysis because
of insufficient data to allow pooling of outcomes. Individual and pooled estimates are shown
in Figure C in S1 File, Forest plot from individual studies and meta-analysis for mortality.
Overall, results showed that CDS interventions had a marginal statistically significant effect on
Systematic review of computerised decision support on antibiotic use
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mortality based on the random effects model. [OR = 0.85, 95% CI, 0.75 to 0.96, p = 0.01].
There was evidence of heterogeneity between studies (Chi2 = 42.37, df = 20, I2 = 53%,
p = 0.01).
There was no evidence of an effect of CDS interventions on mortality for Cochrane compli-
ant studies (N = 5) [OR = 0.88, 95% CI, 0.75 to 1.04, p = 0.13]. Based on non-Cochrane studies
(N = 16), there was a marginal statistically significant effect of CDS interventions on mortality
[OR = 0.84, 95% CI, 0.71 to 0.99, p = 0.04] (Figure C in S1 File, Forest plot from individual
studies and meta-analysis for mortality.).
Volume of antibiotic usage. Nineteen studies reported on the impact of CDS on the vol-
ume of antibiotic usage.[20,26,32,33,36,37,39,44,46,48,50–58]. Values for total antibiotic use
are summarised in Table 2. Fourteen studies showed decreases in antibiotic usage.
[26,33,36,37,39,44,46,48,52,53,55–58] Two studies showed increases in antibiotic usage.[32,50]
One study by Fisher and co-workers showed conflicting results as intravenous DDDs signifi-
cantly decreased by 11.1% (p = 0.002), but was coupled with a compensatory increase in oral
DDDs of 3.7% (p = 0.002).[20] The unit of measurement for drug use differed between studies,
making it difficult to compare the impact of each intervention. A study by Burke and co-
workers demonstrated an unexpected increase in DDDs which may be attributed to the declin-
ing ICU length of stay.[32] Thursky and co-workers showed a significant reduction of antibi-
otic DDDs (1660 to 1490 DDDs/1000 ICU bed-days), which was accompanied by a significant
decrease in proportion of patients who received broad spectrum antibiotics.[26]
Length of stay. Values for length of stay are summarised in Table 3. Sixteen studies
showed decreases in length of stay.[24,25,30,32,34,36,37,40,41,43–45,49,52,53,59] Three
Table 2. Reduction in overall antibiotic usage with CDS interventions in secondary care.













Buising 2008 DDD/1000 bed-days +1.41 -0.16 - N/A
Burke 1999 DDD/1000 pt-days 226 299 +32% N/A
Burton 1991 DOT 8.3 7.3 -12% 0.93
Chan 2011 Gradient DDD/1000 pt-days +0.916 +0.6437 - N/A
Cook 2011 DDD/1000 pt-days 775.3 552.2 -28.8% < 0.0001
Evans 1998 DDD/1000 pt-days 1852 1619 -13% N/A
Evans 1999 DDD/1000 pt-days 1972 1882 -4.5% N/A








Grayson 2004 DDD/1000 pt-days N/A N/A N/A N/A
Linares 2011 Antibiotic days 6.3 2.2 -65% < 0.001
Mullett 2001 Doses/patient 19.8 22 +11% N/S
Pestotnik 1996 DDD/1000 pt-days 359 277 -23% N/A
Shojania 1998 Antimicrobial orders/prescriber 16.7 11.3 -32% 0.04
Sintchenko 2003 DDD/1000 pt-days 1925 1606 -17% 0.04
Staicu 2016 DOT/1000 pt-days 9.5 4.4 -54% < 0.0001
Tafelski 2010 Antimicrobial agents/day 1.5 1.3 -13% 0.05
Thursky 2006 DDD/1000 pt-days 1670 1490 -11% N/A
Yong 2010 DDD/1000 pt-days N/A N/A N/A N/S
DDD, defined daily doses; DOT, duration of therapy, AB, antibiotics; N/A, not reported; N/S, not significant; PO, Oral; IV, intravenous.
https://doi.org/10.1371/journal.pone.0183062.t002
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studies showed increases in length of stay.[2,20,60] Three studies showed no change in length
of stay.[18,50,61] Three further studies reported conflicting effects of CDS on length of stay
across different intervention arms.[33,35]
Cost of antibiotics. Fifteen studies reported on the impact of CDS on antibiotic cost.
[18,20,24,27,29,31,33,34,36,44,50,52,55,59,62] Values for cost of antibiotic use are summarised
in Table 4. The unit of cost report varied making it difficult to measure the overall impact of
CDS. Nine studies showed decreases in cost of antimicrobials after implementing CDS.
[24,27,34,36,44,50,52,59] Four studies showed increases in cost of antibiotics following CDS
implementation.[18,20,31,50] Two studies reported conflicting results on antibiotic costs.
[31,33] In the study conducted by Evans and co-workers, the cost of antibiotics per patient
decreased when CDS recommendations were adopted ($340 vs. $102).[33] In contrast, the
cost of antibiotics per patient increased when CDS recommendations were overridden
($340 vs. $427).[33] The study by Buising and co-workers showed that CDS was superior to
baseline and inferior to academic detailing in cost saving.[31] However Paul and co-workers
Table 3. Length of stay associated with CDS implementation.
Study Length of stay in non-intervention group Length of stay in intervention group Difference P value
Agwu 2008 6.78 days 6.67 days -1.62% 0.65
Arboe 2014 - - No change N/A






Burke 1999 10.28 days 8.84 days -14% N/A
Burton 1991 20.3 days 16 days -21% 0.028
Chow 2013 9.6 8.1 -15.6 N/A
Dean 2015 3.1 days (baseline)
3.0days (second period)
3.0days(baseline)




Evans 1995 6.2 days 5.8 days -6.5% N/S
Evans 1998 12.9days
12.9days





Evans 1999 8.5 days 7.9 days -7% N/A
Guiliano 2011 15.7 days 17.8 days +13% 0.58
Fisher 2003 N/A N/A +1.9% N/A
Kim 2013 23 days 19.5 days -15.2% 0.036
King 2007 2.8 days 2.9 days +3.45% 0.125
McGregor 2006 3.99 days 3.84 days -3.75% 0.38
Mullett 2004 N/A N/A No change N/A







Paul 2006 9.45 days 8.83 days -6.5% 0.055
Pestotnik 1996 7.5 days 7.3 days -2.7% N/A









Rohrig 2008 15.6 days 11.25 days -27.9 N/A
Sintchenko 2004 7.15 days 6.22 days -13% 0.02
Thiel 2009 28.7 days 22.4 days -22% 0.02
LRMs, local resistance maps; PMRTRs, preliminary microbiological reports with therapeutic recommendations; N/A, not reported; N/A, not stated
https://doi.org/10.1371/journal.pone.0183062.t003
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(25) reported no difference in antibiotic costs associated with observed side effects between
CDS and control groups. No study reported on the overall costs of implementation of CDS.
Compliance with guidelines. Ten studies reported on the impact of CDS on compliance
with guidelines.[19,28,31,35,51,60,63–66] Values for the percentage of compliance with guide-
lines are summarised in Table 5. CDS effects were measured as absolute percentage differences
between CDS and intervention groups. All studies demonstrated that CDS improved adher-
ence to guidelines (see Table 5). Guiliano and co-workers showed that CDS improved
Table 4. Antibiotic cost reductions associated with CDS interventions.





Agwu 2008 N/A N/A N/A -21.6% N/A
Arboe 2014 N/A N/A N/A Increased N/A





Evans 1994 Cost of antibiotics per day $51.93 $41.08 -21% <0.001
Evans 1995 Cost of antibiotic per patient $382.68 $295.65 -23% N/A





Evans 1999 Average cost of antibiotics $128 $98.06 -23.4% < 0.004
Fisher 2003 N/A N/A N/A +12% N/A
Kofoed 2009 Total cost of antibiotics per patient in Euro €469 €482 +2.8% 0.77
McGregor 2006 Total cost of antimicrobials $370,006 $285,812 -23% N/A
Mullett 2004 Cost of antibiotic per patient $274.79 $289.60 +5% NS
Paul 2006 Total cost of antibiotic in Euro €623.2 €565.4 -9% 0.007
Pestotnik 1996 Antibiotic cost per patient $122.66 $51.90 -58% -
Potasman 2012 Total antibiotic expenditure 4.1 million NIS 3.4 million NIS -17% N/A
Shojania 1998 Annual cost of antibiotics N/A N/A $90,000/year N/A
N/A not reported, N/S not significant, NIS = New Israeli Shekel
https://doi.org/10.1371/journal.pone.0183062.t004
Table 5. Compliance associated with CDS.
Study Compliance in non-intervention group Compliance in intervention group Difference P value
Buising 2008 65% (baseline)
75% (academic detailing)
85% (CDS)




















Karsies 2014 15% 76% +61%









Revolinski 2015 69.7% 71.2% +1.5% 0.605
Tafelski 2010 39.8% 90.8% 51% <0.05
Van Sise 2012 85.7% 92.6% +6.9% <0.005
Westphal 2011 49% 67% +18% <0.001
Grayson 2004 N/A 76% N/A N/A
N/A, not reported; CDS, clinical decision support
https://doi.org/10.1371/journal.pone.0183062.t005
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adherence to sepsis resuscitation and management bundles.[60] Tafelski and co-workers
showed that ICU mortality was significantly increased in low adherence group (LAG) com-
pared to high adherence group (HAG) (OR = 2.43, 95% CI 1.126 to 5.243).[39]
Antimicrobial resistance. Four studies reported on AMR.[36,46,48,54] In a study by
Chan and co-workers, the rate of methicillin resistant Staphylococcus aureus (MRSA)
decreased from 65–70% before the implementation of the antimicrobial approval system in
2003 to less than 60% in 2009.[46] Buising and co-workers showed a trend after the introduc-
tion of an antimicrobial approval system towards increased susceptibility of S. aureus to methi-
cillin and increasing susceptibility of Pseudomonas spp. isolates to both carbapenems and
aminoglycosides.[48]
Use and implementation. Fifteen studies assessed aspects of the use and implementation
of CDS, such as user satisfaction,[2,33,52,67–69] user uptake,[37,48,59,68] and acceptance of
CDS recommendations.[38,46,50,51,59,70,71,72] Six studies showed improvement of user
uptake and satisfaction. In a study by Chow and co-workers, the proportion of times when
CDS was used when antibiotics were prescribed increased from 23% in phase (1) to 38% in
phase (2) and to 87% in phase (3).[70] CDS recommendations were accepted in 40% to 89% of
cases. Buising and co-workers showed that the use of an approval system increased between
2005 and 2006 and reached a plateau of 250–300 new approvals per month.[48]. Stevenson
and colleagues showed that agreement with CDS recommendations had a pooled odds ratio
(1.88, 95% CI, 1.01–3.56, p = 0.04).[38] In contrast, six studies showed poor user uptake of
CDS recommendations. In a study by Hum and co-workers, 37% of those eligible used CDS
while working in a Neonatal Intensive Care Unit.[68] Sintchenko and co-workers [73] showed
a low level of CDS adoption as only one third of CDS recommendations were accepted, while
Evans and co-workers showed that 37% of CDS recommendations were accepted.
Discussion
Main findings
Evidence for the impact of CDS on antibiotic use in hospital inpatient settings has been
reviewed systematically. Almost half of the studies included in the present systematic review
did not appear in previous systematic reviews. This highlights the pace of the introduction and
evaluation of health information technology in hospital settings. Therefore, this systematic
review extends previous evidence, including studies never evaluated previously.
Studies were extremely variable in the types of CDS interventions and in the outcomes
assessed. The most commonly assessed outcomes were mortality, length of stay, volume of
antibiotic use and adequacy of antibiotic coverage. Other outcomes assessed included system
uptake, antimicrobial resistance, cost and compliance with guidelines. Only a small number of
studies of this systematic review assessed health outcomes (mortality and adequacy of antibi-
otic coverage) which may limit the strength of evidence needed to reflect on CDS design, selec-
tion and implementation.
The principal findings of the meta-analysis indicate evidence that some studies of CDS
interventions were associated with improvements in adequacy of antibiotic coverage (by more
than 100%) and patient mortality (reducing the risk of death by about 15%). However, these
findings were likely to be driven by data from poor quality studies. Increases in compliance
with guidelines have been noted in the present review. Drawing conclusions about the effects
of CDS on length of stay and cost of antibiotics is difficult since results from the present review
are conflicting. A meta-analysis by Baysari and co-workers (9) showed similar findings of the
impact of CDS interventions on adequacy of antibiotic coverage The current systematic review
indicated conflicting results on CDS uptake as some studies showed improved uptake while
Systematic review of computerised decision support on antibiotic use
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other showed poor adoption. A study by Demonchy and coworkers[19], has highlighted
uptake and implementation issues of CDS as a major barrier. The impact of CDS interventions
would have been greater if used regularly by prescribers.
Strengths
This systematic review provides a comprehensive, up-to-date overview of CDS interventions
aimed at optimising antibiotic use in the hospital inpatient setting. A wide range of outcome
measures was assessed including outcomes that have not been previously evaluated, such as
cost, system uptake and antimicrobial resistance. It is noteworthy that non-randomised
designs have been commonly utilised in evaluations of health informatics developments, as
evidenced by this systematic review. The present review included studies that have not been
included in other systematic reviews.
Given that the quality and study design of included studies were generally poor and the het-
erogeneity in respect of study quality and end points, the synthesis of the studies was problem-
atic. However, it was possible to conduct meta-analysis and subgroup analysis which adds to
the strength of this review.
Limitations and future research
The present systematic review is limited by the quality of studies included for analysis coupled
with limitations inherent in the applied methods. All studies were eligible for inclusion in the
meta-analysis but information contained in studies enabled meta-analysis to be conducted for
two outcomes: adequacy of antibiotic coverage (n = 13 studies) and mortality (n = 20 studies).
The number of studies that reported other outcome measures (e.g. volume of antibiotic use
and cost) in a uniform way was not sufficient for other meta-analysis to be conducted.
Heterogeneity in study designs, CDS interventions, outcomes, implementation and contex-
tual factors make it difficult to reach firm conclusions about the impact of CDS. Subgroup anal-
ysis was not successful in explaining or even reducing heterogeneity across subgroups. This
indicates that heterogeneity was inherent in poor methodological and intervention designs.
There is a possibility that selective reporting may reduce the validity of some of the conclu-
sions. A marginal reduction of mortality is a key finding of from this systematic review; how-
ever, this finding is based on a limited number of studies (n = 20). Selective reporting could
not be controlled, as it is not clear how many studies that might have found an increase in
mortality it would take to nullify or even reverse the findings here. Therefore, an assurance
that there is no risk of an increase in mortality is not possible. Caution needs to be applied
with regards to the possibility of publication bias or evaluation by developers. It should be
clear that an external evaluation should be reported using accepted mixed methods research.
There is a lack of literature about the impact of CPOE without explicit CDS from commercial
vendors: this may be due to publication bias.
Future work should include conducting high quality systematic multi-site comparative
studies of different CDS interventions for antibiotic prescribing. More qualitative work is
required to highlight the barriers and facilitators of adopting CDS technology and better
understanding users’ perceptions and attitudes towards CDS interventions to trigger high
adoption and uptake by providers.
Conclusion
This review indicates that CDS interventions can be effective in optimising antibiotic use in
hospitals. The findings of this review can be used to enrich the debate around the impact of
CDS on antibiotic optimisation. This review demonstrates the efficacy of CDS in optimising
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the adequacy of antibiotic coverage across different settings. However, evidence on the effect
of CDS on clinical outcomes, economic outcomes and volume of antibiotic use was limited.
CDS appears to be safe because the present review has not shown any significant risks such as
worsening mortality or length of stay. CDS presents a promising future for optimising antibi-
otic use and improving patient care. However, in order to reach firm conclusions about the
impact of CDS on antibiotic use, more high quality studies are needed within different settings
and in different health systems.
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